Status:
COMPLETED
Microneedling for Acquired Hypomelanosis
Lead Sponsor:
Cairo University
Conditions:
Acquired Hypomelanosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acquired hypomelanosis is a type of cutaneous melanocytopenic hypomelanosis, denoting the lightening of the skin due to a reduction in the number of epidermal and/or follicular melanocytes secondary t...
Detailed Description
The aim of this study to evaluate the efficacy and safety of microneedling as a treatment model for patients with acquired hypomelanosis. Patients with an acquired hypomelanosis from outpatient clini...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Localized acquired hypomelanosis secondary to any insult, post-inflammatory or iatrogenic of no more than 2 years duration, affecting any anatomical site except genitalia, of any size larger than 3 cm in diameter.
- Patients older than 18 years old, consenting to go through the microneedling procedure.
- Both genders.
- Exclusion criteria:
- Congenital and hereditary hypomelanosis.
- Vitiligo
- Pregnancy and lactation.
- Patients with history of any autoimmune disease.
- Patients with history of keloids formation.
- Patient on systemic steroids, retinoids, immunosuppressant or anticoagulant therapy.
Exclusion
Key Trial Info
Start Date :
September 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04419350
Start Date
September 15 2019
End Date
May 1 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 35855